This section includes testimony by FDA officials before House and Senate Committees and Subcommittees. For testimony from previous years, see the FDA Archive.

Office of Legislation

Search

Date	Testimony	Speaker	Excerpt
02/08/2023	The Federal Response to COVID-19 - 02/08/2023	Robert Califf
09/14/2022	Stopping the Spread of Monkeypox: Examining the Federal Response - 09/14/2022	Robert Califf
07/20/2022	Oral Testimony of FDA Commissioner Robert M. Califf, M.D., on the FDA Foods Program - 07/20/2022	Robert Califf
06/16/2022	An Update on the Ongoing Federal Response to COVID-19: Current Status and Future Planning - 06/16/2022	Robert Califf
05/26/2022	Infant Formula Crisis: Addressing the Shortages and Getting Formula on the Shelves - 05/26/2022	Robert Califf
05/25/2022	Formula Safety and Supply: Protecting The Health Of America’s Babies - 05/25/2022	Robert Califf, Frank Yiannas, Susan Mayne,
04/26/2022	FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients, FDA Center Directors - 04/26/2022	Patrizia Cavazzoni, Peter Marks, Jeffrey Shuren
04/01/2022	FDA User Fee Reauthorization: Ensuring Safe and Effective Medical Devices - 04/01/2022	Jeffrey Shuren
02/03/2022	FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics - 02/03/2022	Patrizia Cavazzoni, Peter Marks
01/11/2022	Addressing New Variants: A Federal Perspective On The Covid-19 Response - 01/11/2022	Janet Woodcock

Download XLSX